newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced that the underwriters of its previously announced underwritten public offering exercised in full the